Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023

1M ago

DXR

PremiumPress Releases

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders

1M ago

DXR

PremiumPress Releases

Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base

2M ago

DXR

PremiumPress Releases

Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure Patients

2M ago

DXR

More DXR News >

DXR News on the Web

2024-04-16

New Studies Prove the Clinical Benefits of Daxor’s Blood Volume Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion

Yahoo Finance

Neutral

2024-04-15

DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC

Yahoo Finance

Neutral

2024-04-10

Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital

Yahoo Finance

Neutral

2024-04-01

Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24

Yahoo Finance

Neutral

2024-03-28

Daxor Corporation Q4 2023 Earnings Call Transcript

Yahoo Finance

Bullish

2024-03-25

Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics

Yahoo Finance

Bullish

2024-03-22

Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024

Yahoo Finance

Neutral

2024-03-18

Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023

Yahoo Finance

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DXR’s Media Buzz Sentiment?

Currently, no data Available

What is DXR’s weekly average amount of articles?

Currently, no data Available

What is DXR’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

NBIXNeurocrine

AMEDAmedisys

HSTMHealthStream

IMVTImmunovant

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing